Aidoc won FDA clearance for a 'foundation model' clinical AI that triages 14 abdomen-CT indications in one workflow, aiming ...
Enterprise-grade AI reduces operational cost, accelerates customer resolution, and establishes a scalable automation blueprint ...
Thomson Reuters Corporation is rated a Buy with expectations for topline acceleration in FY2026. Learn more about TRI stock ...
The strategic collaboration will help customers increase velocity without sacrificing compliance or risking data ...
Aidoc, the pioneer and global leader of clinical AI, today announced that the U.S. Food and Drug Administration (FDA) has cleared the healthcare industry's first comprehensive AI triage solution[1],[2 ...
Marks the company’s third consecutive placement as a Leader following recognition as highest in execution in 2023 and ...
A new year brings new opportunities – and firms investing in private markets are entering 2026 with a focus on moving from AI ...
AI Solutions Enable Providers to Submit Complete Orders in less than 60 seconds, Reduce Suppliers’ Costs by 33%+ and Start 97% of Patients' Care on TimeNEW YORK--(BUSINESS WIRE)--Today, Tomorrow ...
This shift has pushed continuous replication out of the disaster recovery niche and into the category of frontline cyber ...
Traffic is one of the most complex challenges smart cities face--but it's also one of the most solvable with the right mix of technology and policy. ANPR provides the missing link between visibility ...
Learn how multi-agent orchestration enables the next generation of intelligent enterprises by coordinating autonomous AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback